Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104476156> ?p ?o ?g. }
- W2104476156 endingPage "272" @default.
- W2104476156 startingPage "262" @default.
- W2104476156 abstract "The majority of patients receiving the platinum-based chemotherapy drug oxaliplatin develop peripheral neurotoxicity. Because this neurotoxicity involves ROS production, we investigated the efficacy of mangafodipir, a molecule that has antioxidant properties and is approved for use as an MRI contrast enhancer.The effects of mangafodipir were examined in mice following treatment with oxaliplatin. Neurotoxicity, axon myelination, and advanced oxidized protein products (AOPPs) were monitored. In addition, we enrolled 23 cancer patients with grade ≥ 2 oxaliplatin-induced neuropathy in a phase II study, with 22 patients receiving i.v. mangafodipir following oxaliplatin. Neuropathic effects were monitored for up to 8 cycles of oxaliplatin and mangafodipir.Mangafodipir prevented motor and sensory dysfunction and demyelinating lesion formation. In mice, serum AOPPs decreased after 4 weeks of mangafodipir treatment. In 77% of patients treated with oxaliplatin and mangafodipir, neuropathy improved or stabilized after 4 cycles. After 8 cycles, neurotoxicity was downgraded to grade ≥ 2 in 6 of 7 patients. Prior to enrollment, patients received an average of 880 ± 239 mg/m2 oxaliplatin. Patients treated with mangafodipir tolerated an additional dose of 458 ± 207 mg/m2 oxaliplatin despite preexisting neuropathy. Mangafodipir responders managed a cumulative dose of 1,426 ± 204 mg/m2 oxaliplatin. Serum AOPPs were lower in responders compared with those in nonresponders.Our study suggests that mangafodipir can prevent and/or relieve oxaliplatin-induced neuropathy in cancer patients. Trial registration. Clinicaltrials.gov NCT00727922. Funding. Université Paris Descartes, Ministère de la Recherche et de l'Enseignement Supérieur, and Assistance Publique-Hôpitaux de Paris." @default.
- W2104476156 created "2016-06-24" @default.
- W2104476156 creator A5013591523 @default.
- W2104476156 creator A5016638923 @default.
- W2104476156 creator A5034892075 @default.
- W2104476156 creator A5038293102 @default.
- W2104476156 creator A5041347383 @default.
- W2104476156 creator A5056283668 @default.
- W2104476156 creator A5060607593 @default.
- W2104476156 creator A5061904479 @default.
- W2104476156 creator A5065121477 @default.
- W2104476156 creator A5073611338 @default.
- W2104476156 creator A5073786248 @default.
- W2104476156 creator A5088948541 @default.
- W2104476156 creator A5090375155 @default.
- W2104476156 creator A5091487792 @default.
- W2104476156 date "2013-12-20" @default.
- W2104476156 modified "2023-10-18" @default.
- W2104476156 title "Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir" @default.
- W2104476156 cites W1163687489 @default.
- W2104476156 cites W1509834006 @default.
- W2104476156 cites W1967790114 @default.
- W2104476156 cites W1968787089 @default.
- W2104476156 cites W1978123764 @default.
- W2104476156 cites W1978803477 @default.
- W2104476156 cites W1981670005 @default.
- W2104476156 cites W1989171626 @default.
- W2104476156 cites W1990003678 @default.
- W2104476156 cites W2002628032 @default.
- W2104476156 cites W2006613730 @default.
- W2104476156 cites W2007389646 @default.
- W2104476156 cites W2009902459 @default.
- W2104476156 cites W2010413751 @default.
- W2104476156 cites W2011665876 @default.
- W2104476156 cites W2013116510 @default.
- W2104476156 cites W2014004239 @default.
- W2104476156 cites W2025203808 @default.
- W2104476156 cites W2025392289 @default.
- W2104476156 cites W2042641359 @default.
- W2104476156 cites W2059839512 @default.
- W2104476156 cites W2061134316 @default.
- W2104476156 cites W2078500674 @default.
- W2104476156 cites W2084268808 @default.
- W2104476156 cites W2085967834 @default.
- W2104476156 cites W2096610541 @default.
- W2104476156 cites W2102583849 @default.
- W2104476156 cites W2114519659 @default.
- W2104476156 cites W2115995125 @default.
- W2104476156 cites W2121368761 @default.
- W2104476156 cites W2123522220 @default.
- W2104476156 cites W2128519670 @default.
- W2104476156 cites W2133944806 @default.
- W2104476156 cites W2137056778 @default.
- W2104476156 cites W2148622949 @default.
- W2104476156 cites W2150759929 @default.
- W2104476156 cites W2152706544 @default.
- W2104476156 cites W2155077495 @default.
- W2104476156 cites W2156726799 @default.
- W2104476156 cites W2161339168 @default.
- W2104476156 cites W2161636334 @default.
- W2104476156 cites W2171232394 @default.
- W2104476156 cites W2171740867 @default.
- W2104476156 cites W2175773713 @default.
- W2104476156 cites W4239227502 @default.
- W2104476156 doi "https://doi.org/10.1172/jci68730" @default.
- W2104476156 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3871222" @default.
- W2104476156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24355920" @default.
- W2104476156 hasPublicationYear "2013" @default.
- W2104476156 type Work @default.
- W2104476156 sameAs 2104476156 @default.
- W2104476156 citedByCount "60" @default.
- W2104476156 countsByYear W21044761562013 @default.
- W2104476156 countsByYear W21044761562014 @default.
- W2104476156 countsByYear W21044761562015 @default.
- W2104476156 countsByYear W21044761562016 @default.
- W2104476156 countsByYear W21044761562017 @default.
- W2104476156 countsByYear W21044761562018 @default.
- W2104476156 countsByYear W21044761562019 @default.
- W2104476156 countsByYear W21044761562020 @default.
- W2104476156 countsByYear W21044761562021 @default.
- W2104476156 countsByYear W21044761562022 @default.
- W2104476156 countsByYear W21044761562023 @default.
- W2104476156 crossrefType "journal-article" @default.
- W2104476156 hasAuthorship W2104476156A5013591523 @default.
- W2104476156 hasAuthorship W2104476156A5016638923 @default.
- W2104476156 hasAuthorship W2104476156A5034892075 @default.
- W2104476156 hasAuthorship W2104476156A5038293102 @default.
- W2104476156 hasAuthorship W2104476156A5041347383 @default.
- W2104476156 hasAuthorship W2104476156A5056283668 @default.
- W2104476156 hasAuthorship W2104476156A5060607593 @default.
- W2104476156 hasAuthorship W2104476156A5061904479 @default.
- W2104476156 hasAuthorship W2104476156A5065121477 @default.
- W2104476156 hasAuthorship W2104476156A5073611338 @default.
- W2104476156 hasAuthorship W2104476156A5073786248 @default.
- W2104476156 hasAuthorship W2104476156A5088948541 @default.
- W2104476156 hasAuthorship W2104476156A5090375155 @default.
- W2104476156 hasAuthorship W2104476156A5091487792 @default.
- W2104476156 hasBestOaLocation W21044761561 @default.